Meclizine for Hepatocellular Carcinoma
NCT03253289
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
13
Enrollment
OTHER
Sponsor class
Conditions
Carcinoma, Hepatocellular
Interventions
DRUG:
Meclizine Oral Tablet
Sponsor
Tannaz Armaghnay